ClearBridge Small-Cap Growth Strategy Adds New Positions, Exits Others
Analysts Conflicted on These Healthcare Names: Irhythm Technologies (IRTC), Penumbra (PEN) and Evolus (EOLS)
Penumbra (PEN) Receives a Hold From RBC Capital
Citi Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $350
Citi Sticks to Its Hold Rating for Penumbra (PEN)
Penumbra Initiates FORWARD Trial To Collect Safety, Efficacy Data On Mechanical Thrombectomy
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
Evercore Maintains Penumbra(PEN.US) With Buy Rating, Cuts Target Price to $320
Record-setting Healthcare M&A Activity to Extend Through H2: PwC
Penumbra Shareholders Back Directors, Auditor and Pay Policies
Penumbra Gets CE Mark for Thunderbolt Stroke Device in Europe
Penumbra's Thunderbolt Device Offers Revenue Upside Not Reflected in Estimates, RBC Says
Wells Fargo Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $374
Penumbra Receives FDA Clearance for Thunderbolt
Penumbra's THUNDERBOLT Gets FDA Clearance To Treat Acute Ischemic Stroke
CCORF Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $374
Canaccord Genuity Reaffirms Their Hold Rating on Penumbra (PEN)
Tudor Adds Warner Bros. Discovery Stake, Boosts SPY, Trims QQQ in Q1
Penumbra Is Maintained at Neutral by Citigroup
Penumbra Is a 'Strong' Strategic Fit for Boston Scientific, RBC Says